PATH Program


Advancing and increasing access to quality and appropriate diagnostics that improve the health outcomes of people and communities in low-resource settings.

Read more


What we do

Diagnostics are the cornerstone of universal health coverage, emergency response, and population well-being. They are indispensable for guiding clinical decisions, averting drug resistance, bolstering disease surveillance, and raising early alerts of potential pandemics. Unfortunately, more than half of the world's population lacks access to even the most basic diagnostic tools. In many regions, these critical diagnostics are either entirely absent where patients seek treatment or too expensive or resource-intensive for local healthcare systems.

For over 3 decades, PATH has collaborated with partners across the full diagnostics ecosystem to develop and commercialize appropriate, affordable, quality-assured diagnostics for conditions that disproportionately affect people in low-resource settings. With a global presence and country-specific capabilities, PATH is accelerating the delivery and accessibility of essential health products, ensuring that no one is left behind on the path to better health.

Our focus areas

Partner with us

Are you working on, or interested in diagnostics?

Diagnostics Leadership

  1. Neha Agarwal

    Co-Lead, Diagnostics

  2. David Boyle

    Laboratory Director and Program Co-Lead, Diagnostics

  3. Jennifer Chin

    Director of Finance & Operations, Diagnostics

  4. Gonzalo Domingo

    Scientific Director and Lead of Malaria Diagnostics

  5. Bhavya Gowda

    Lead, Market Access and Commercialization

  6. Deborah Oroszlan

    Digital Engagement & Communications

  7. Roger Peck

    Associate Director, Diagnostics

  8. Helen Storey

    Program Advisor, Diagnostics

43 Article s